Você procurou por: bijosimili (Maltês - Inglês)

abseamed huwa mediċina ‘bijosimili’.
abseamed is a ‘biosimilar’ medicine.

‘inflectra huwa mediċina ‘bijosimili’.
‘inflectra is a ‘biosimilar’ medicine.

abasaglar hu prodott mediċinali bijosimili.
abasaglar is a biosimilar medicinal product.

filgrastim hexal huwa mediċina ‘bijosimili’.
filgrastim hexal is a ‘biosimilar’ medicine.

epoetin alfa hexal huwa mediċina ‘bijosimili’.
epoetin alfa hexal is a ‘biosimilar’ medicine.

alpheon ġie żviluppat bħala mediċina ‘ bijosimili ’.
alpheon was developed as a ‘ biosimilar’ medicine.

benepali fih is-sustanza attiva etanercept u huwa ‘mediċina bijosimili’.
benepali contains the active substance etanercept and is a ‘biosimilar medicine’.

għal aktar informazzjoni dwar il-mediċini bijosimili, ara d- dokument mistoqsija u tweġiba hawn
for more information on biosimilar medicines, see the question-and-answer document here.

għal aktar informazzjoni dwar mediċini bijosimili, ara d-dokument ta’ mistoqsijiet u tweġibiet hawn.
for more information on biosimilar medicines, see the question-and-answer document here.

għal aktar informazzjoni dwar il- mediċini bijosimili, ara d-dokument ta' mistoqsija u tweġiba hawn.
for more information on biosimilar medicines, see the question-and-answer document here.

għal aktar informazzjoni dwar mediċini bijosimili, ara d-dokument ta’ mistoqsija u t-tweġiba hawnhekk.
for more information on biosimilar medicines, see the question-and-answer document here.

għal aktar informazzjoni dwar il-mediċini bijosimili, ara d-dokument ‘mistoqsijiet u tweġibiet’ hawnhekk.
for more information on biosimilar medicines, see the question-and-answer document here.

għal aktar informazzjoni dwar mediċini bijosimili, ara d-dokument ta’ mistoqsija-u-tweġiba li jinsab hawn.
for more information on biosimilar medicines, see the question-and-answer document here.

l- aġenzija ser timplimenta għadd ta 'linji gwida adottati relatati ma' prodotti bijoloġiċi simili (bijosimili), u ser tikkonsolida l- proċeduri għal mediċini ġeneriċi.
the agency will implement a number of adopted guidelines relating to similar biological (biosimilar) medicinal products, and will consolidate procedures for generic medicines.